Cardioprotection during diabetes: The role of mitochondrial DNA

Anesthesiology

Volumn 120, Issue 4, 2014, Pages 870-879

  Muravyeva, Maria ^a   Baotic, Ines ^a   Bienengraeber, Martin ^a   Lazar, Jozef ^a   Bosnjak, Zeljko J ^a   Sedlic, Filip ^a   Warltier, David C ^a   Kersten, Judy R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DICHLOROFLUORESCEIN; FLAVOPROTEIN; ISOFLURANE; MITOCHONDRIAL DNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN METABOLITE; INHALATION ANESTHETIC AGENT; SCAVENGER;

ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART PROTECTION; HEMODYNAMICS; MALE; MITOCHONDRIAL GENOME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ANIMAL; DISEASE MODEL; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ACETYLCYSTEINE; ANESTHETICS, INHALATION; ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DNA, MITOCHONDRIAL; FREE RADICAL SCAVENGERS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLURANE; MALE; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 84901722066     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000107     Document Type: Article

References (38)

1. Achilli A, Olivieri A, Pala M, Hooshiar Kashani B, Carossa V, Perego UA, Gandini F, Santoro A, Battaglia V, Grugni V, Lancioni H, Sirolla C, Bonfigli AR, Cormio A, Boemi M, Testa I, Semino O, Ceriello A, Spazzafumo L, Gadaleta MN, Marra M, Testa R, Franceschi C, Torroni A: Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole. PLoS One 2011; 6:e21029.
2. Lowell BB, Shulman GI: Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307:384-7.
3. Wang SL, Head J, Stevens L, Fuller JH: Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The World Health Organization multinational study of vascular disease in diabetes. Diabetes Care 1996; 19:305-12.
4. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H: Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44(suppl 2):S14-S21.
5. Burwell LS, Brookes PS: Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury. Antioxid Redox Signal 2008; 10:579-99.
6. Nobrega MA, Fleming S, Roman RJ, Shiozawa M, Schlick N, Lazar J, Jacob HJ: Initial characterization of a rat model of diabetic nephropathy. Diabetes 2004; 53:735-42.
7. Kimura K, Toyota T, Kakizaki M, Kudo M, Takebe K, Goto Y: Impaired insulin secretion in the spontaneous diabetes rats. Tohoku J Exp Med 1982; 137:453-9.
8. Goto Y, Kakizaki M, Masaki N: Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 1976; 119:85-90.
9. Kuijpers MH, Gruys E: Spontaneous hypertension and hypertensive renal disease in the fawn-hooded rat. Br J Exp Pathol 1984; 65:181-90.
10. Simons JL, Provoost AP, Anderson S, Troy JL, Rennke HG, Sandstrom DJ, Brenner BM: Pathogenesis of glomerular injury in the fawn-hooded rat: Early glomerular capillary hypertension predicts glomerular sclerosis. J Am Soc Nephrol 1993; 3:1775-82.
11. Sethumadhavan S, Vasquez-Vivar J, Migrino RQ, Harmann L, Jacob HJ, Lazar J: Mitochondrial DNA variant for complex I reveals a role in diabetic cardiac remodeling. J Biol Chem 2012; 287:22174-82.
12. Ludwig LM, Patel HH, Gross GJ, Kersten JR, Pagel PS, Warltier DC: Morphine enhances pharmacological preconditioning by isoflurane: Role of mitochondrial K(ATP) channels and opioid receptors. Anesthesiology 2003; 98:705-11.
13. Ludwig LM, Weihrauch D, Kersten JR, Pagel PS, Warltier DC: Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: Potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. Anesthesiology 2004; 100:532-9.
14. Marinovic J, Bosnjak ZJ, Stadnicka A: Distinct roles for sarcolemmal and mitochondrial adenosine triphosphate-sensitive potassium channels in isoflurane-induced protection against oxidative stress. Anesthesiology 2006; 105:98-104.
15. Hüser J, Rechenmacher CE, Blatter LA: Imaging the permeability pore transition in single mitochondria. Biophys J 1998; 74:2129-37.
16. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ: Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000; 192:1001-14.
17. Pravdic D, Sedlic F, Mio Y, Vladic N, Bienengraeber M, Bosnjak ZJ: Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway. Anesthesiology 2009; 111:267-74.
18. Sedlic F, Sepac A, Pravdic D, Camara AK, Bienengraeber M, Brzezinska AK, Wakatsuki T, Bosnjak ZJ: Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane: Roles of ROS and Ca2+Am J Physiol Cell Physiol 2010; 299:C506-15.
19. Baines CP: The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol 2009; 104:181-8.
20. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC: Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: Reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997; 87:361-70.
21. Hirata N, Shim YH, Pravdic D, Lohr NL, Pratt PF Jr, Weihrauch D, Kersten JR, Warltier DC, Bosnjak ZJ, Bienengraeber M: Isoflurane differentially modulates mitochondrial reactive oxygen species production via forward versus reverse electron transport flow: Implications for preconditioning. Anesthesiology 2011; 115:531-40.
22. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Schaub MC: Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology 2002; 97:4-14.
23. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology 2002; 96:183-8.
24. Tanaka K, Kehl F, Gu W, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR: Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol 2002; 282:H2018-23.
25. Amour J, Brzezinska AK, Jager Z, Sullivan C, Weihrauch D, Du J, Vladic N, Shi Y, Warltier DC, Pratt PF Jr, Kersten JR: Hyperglycemia adversely modulates endothelial nitric oxide synthase during anesthetic preconditioning through tetrahydrobiopterin- And heat shock protein 90-mediated mechanisms. Anesthesiology 2010; 112:576-85.
26. Przyklenk K: Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: The co-morbidity conundrum. Drugs Aging 2011; 28:331-43.
27. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, Abel ED: Mitochondrial energetics in the heart in obesity-related diabetes: Direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007; 56:2457-66.
28. Kevin LG, Novalija E, Stowe DF: Reactive oxygen species as mediators of cardiac injury and protection: The relevance to anesthesia practice. Anesth Analg 2005; 101:1275-87.
29. Sedlic F, Pravdic D, Hirata N, Mio Y, Sepac A, Camara AK, Wakatsuki T, Bosnjak ZJ, Bienengraeber M: Monitoring mitochondrial electron fluxes using NAD(P)H-flavoprotein fluorometry reveals complex action of isoflurane on cardiomyocytes. Biochim Biophys Acta 2010; 1797:1749-58.
30. Schlick NE, Jensen-Seaman MI, Orlebeke K, Kwitek AE, Jacob HJ, Lazar J: Sequence analysis of the complete mitochondrial DNA in 10 commonly used inbred rat strains. Am J Physiol Cell Physiol 2006; 291:C1183-92.
31. Minners J, Lacerda L, McCarthy J, Meiring JJ, Yellon DM, Sack MN: Ischemic and pharmacological preconditioning in Girardi cells and C2C12 myotubes induce mitochondrial uncoupling. Circ Res 2001; 89:787-92.
32. Nakae Y, Kohro S, Hogan QH, Bosnjak ZJ: Intracellular mechanism of mitochondrial adenosine triphosphate-sensitive potassium channel activation with isoflurane. Anesth Analg 2003; 97:1025-32.
33. Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M, Inserte J, Agulló L, Cabestrero A: The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion. Cardiovasc Res 2006; 70:274-85.
34. Miura T, Tanno M: Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury. Cardiovasc Drugs Ther 2010; 24:255-63.
35. Sloan RC, Moukdar F, Frasier CR, Patel HD, Bostian PA, Lust RM, Brown DA: Mitochondrial permeability transition in the diabetic heart: Contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury. J Mol Cell Cardiol 2012; 52:1009-18.
36. Piriou V, Chiari P, Gateau-Roesch O, Argaud L, Muntean D, Salles D, Loufouat J, Gueugniaud PY, Lehot JJ, Ovize M: Desfluraneinduced preconditioning alters calcium-induced mitochondrial permeability transition. Anesthesiology 2004; 100:581-8.
37. Venkatapuram S, Wang C, Krolikowski JG, Weihrauch D, Kersten JR, Warltier DC, Pratt PF Jr, Pagel PS: Inhibition of apoptotic protein p53 lowers the threshold of isofluraneinduced cardioprotection during early reperfusion in rabbits. Anesth Analg 2006; 103:1400-5.
38. Zhu J, Rebecchi MJ, Tan M, Glass PS, Brink PR, Liu L: Ageassociated differences in activation of Akt/GSK-3beta signaling pathways and inhibition of mitochondrial permeability transition pore opening in the rat heart. J Gerontol A Biol Sci Med Sci 2010; 65:611-9.